The endometrial transcriptome of infertile women with and without implantation failure
Acta Obstetricia et Gynecologica Scandinavica · 2024-07 · 103 (7) · 1348-1365
DOI: 10.1111/aogs.14822 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, online erschienen am 22.03.2024. Verfasst von Bich Ngoc Bui und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Reproductive Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Infertility, Female, Endometrium, Transcriptome, Embryo Implantation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Horizon 2020 Framework Program, European Regional Development Fund, EVA (Erfelijkheid Voortplanting & Aanleg) specialty program.
Abstract (Originalsprache)
Introduction
Implantation failure after transferring morphologically “good‐quality” embryos in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) may be explained by impaired endometrial receptivity. Analyzing the endometrial transcriptome analysis may reveal the underlying processes and could help in guiding prognosis and using targeted interventions for infertility. This exploratory study investigated whether the endometrial transcriptome profile was associated with short‐term or long‐term implantation outcomes (ie success or failure). Material and methods Mid‐luteal phase endometrial biopsies of 107 infertile women with one full failed IVF/ICSI cycle, obtained within an endometrial scratching trial, were subjected to RNA‐sequencing and differentially expressed genes analysis with covariate adjustment (age, body mass index, luteinizing hormone [LH]‐day). Endometrial transcriptomes were compared between implantation failure and success groups in the short term (after the second fresh IVF/ICSI cycle) and long term (including all fresh and frozen cycles within 12 months). The short‐term analysis included 85/107 women (33 ongoing pregnancy vs 52 no pregnancy), excluding 22/107 women. The long‐term analysis included 46/107 women (23 ‘fertile’ group, ie infertile women with a live birth after ≤3 embryos transferred vs 23 recurrent implantation failure group, ie no live birth after ≥3 good quality embryos transferred), excluding 61/107 women not fitting these categories. As both analyses drew from the same pool of 107 samples, there was some sample overlap. Additionally, cell type enrichment scores and endometrial receptivity were analyzed, and an endometrial development pseudo‐timeline was constructed to estimate transcriptomic deviations from the optimum receptivity day (LH + 7), denoted as ΔWOI (window of implantation).
Results
There were no significantly differentially expressed genes between implantation failure and success groups in either the short‐term or long‐term analyses. Principal component analysis initially showed two clusters in the long‐term analysis, unrelated to clinical phenotype and no longer distinct following covariate adjustment. Cell type enrichment scores did not differ significantly between groups in both analyses. However, endometrial receptivity analysis demonstrated a potentially significant displacement of the WOI in the non‐pregnant group compared with the ongoing pregnant group in the short‐term analysis.
Conclusions
No distinct endometrial transcriptome profile was associated with either implantation failure or success in infertile women. However, there may be differences in the extent to which the WOI is displaced.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology and Reproductive Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
- Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.
- Competence Center on Health Technologies, Tartu, Estonia.
- Department of Obstetrics and Gynecology, GROW, School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands.
- Center for Medical Genetics, Research Group Reproduction and Genetics, Vrije Universiteit Brussel, Brussels, Belgium.
- Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore), VUB-ULB, Brussels, Belgium.
ORCID-Profile: Bich Ngoc Bui
Förderung
- Horizon 2020 Framework Program
- European Regional Development Fund
- EVA (Erfelijkheid Voortplanting & Aanleg) specialty program
- Eesti Teadusagentuur
- Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España
- Ettevõtluse Arendamise Sihtasutus
- ZonMw
- Merck
Zitieren
APA
Bui, B. N., Kukushkina, V., Meltsov, A., Olsen, C., van Hoogenhuijze, N., Altmäe, S., Mol, F., Teklenburg, G., de Bruin, J. P., Besselink, D., Stevens Brentjens, L., Obukhova, D., Zamani Esteki, M., van Golde, R., Romano, A., Laisk, T., Steba, G., Mackens, S., Salumets, A., & Broekmans, F. (2024). The endometrial transcriptome of infertile women with and without implantation failure. Acta Obstetricia et Gynecologica Scandinavica, 103(7), 1348-1365. https://doi.org/10.1111/aogs.14822
Vancouver
Bui BN, Kukushkina V, Meltsov A, Olsen C, van Hoogenhuijze N, Altmäe S, et al. The endometrial transcriptome of infertile women with and without implantation failure. Acta Obstetricia et Gynecologica Scandinavica. 2024;103(7):1348-1365. doi:10.1111/aogs.14822
BibTeX
@article{Bui2024,
author = {Bui, Bich Ngoc and Kukushkina, Viktorija and Meltsov, Alvin and Olsen, Catharina and van Hoogenhuijze, Nienke and Altmäe, Signe and Mol, Femke and Teklenburg, Gijs and de Bruin, Jan-Peter and Besselink, Dagmar and Stevens Brentjens, Linda and Obukhova, Darina and Zamani Esteki, Masoud and van Golde, Ron and Romano, Andrea and Laisk, Triin and Steba, Gaby and Mackens, Shari and Salumets, Andres and Broekmans, Frank},
title = {The endometrial transcriptome of infertile women with and without implantation failure},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2024},
volume = {103},
number = {7},
pages = {1348--1365},
doi = {10.1111/aogs.14822}
}
EUVIMED